A Proof of Concept Study to Evaluate the Effects of Tasimelteon and Placebo in Travelers With Jet Lag Disorder
Phase of Trial: Phase II
Latest Information Update: 07 Nov 2017
At a glance
- Drugs Tasimelteon (Primary)
- Indications Circadian rhythm sleep disorders; Jet lag
- Focus Proof of concept; Therapeutic Use
- Sponsors Vanda Pharmaceuticals
- 07 Nov 2017 According to a Vanda Pharmaceuticals media release, results from this trial are expected in the fourth quarter of 2017.
- 25 May 2017 Planned number of patients changed from 48 to 90.
- 21 Jan 2017 Status changed from planning to recruiting.